Sarcoma therapeutics market to grow by $1.11b by 2028

The prevalence of patient assistance programmes is driving market growth.

The global market for sarcoma therapeutics will expand by $1.11 by 2028 at a compound annual growth rate (CAGR) of 8.51%, Technavio projected.

A key driver of this expansion is the prevalence of patient assistance programmes, alongside a rising focus on research and development (R&D) for new drugs for sarcoma treatment, particularly osteosarcoma.

Recent advancements include a focus on addressing challenges with current chemotherapy methods, such as side effects and drug resistance.

“Innovative strategies, including nanocarriers for targeted drug delivery, immunotherapy, and targeted therapy, are being explored to enhance treatment outcomes for osteosarcoma patients,” the report said.

Meanwhile, the market is also experiencing a trend towards manufacturing excellence and supply chain optimisation to deliver patient-centric solutions for different sarcoma types.

Follow the link for more news on

report

Also Read

Braillic’s AR tech helps brain surgeons see through the walls

What’s driving growth in India’s oncology market?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit